<DOC>
	<DOCNO>NCT02612181</DOCNO>
	<brief_summary>The investigator preliminary study show dexmedetomidine might improve microcirculation septic shock patient . To test effect , investigator conduct double-blinded study .</brief_summary>
	<brief_title>Dex Microcirculation SS—A Double-blinded Study</brief_title>
	<detailed_description>Dexmedetomidine highly selective α2-adrenoreceptor agonist sedation adult critically ill patient exhibit sedative analgesic effect . Recent study suggest dexmedetomidine restore adrenergic vasoconstrictor responsiveness septic shock , prevents alteration pain rat model intestinal microcirculation Induced surgical stress，even reduce mortality endotoxemic rat patient severe sepsis . The investigator preliminary study show dexmedetomidine might improve microcirculation septic shock patient . To test effect , investigator conduct double-blinded study .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Septic shock patient despite early goal direct therapy Agree participate study Age &lt; 18 Pregnancy Bradycardia ( HR &lt; 55bpm ) Systolic Blood Pressure &lt; 80 mmHg / Mean arterial pressure &lt; 50 mmHg maximal support Death imminent Unlikely survive 90 day Acute liver failure Dementia Highgrade block absence functioning pacemaker .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>dexmedetomidine</keyword>
	<keyword>microcirculation</keyword>
	<keyword>septic shock</keyword>
</DOC>